Neuromodulation for Concussion
(CI-tDCS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a brain stimulation method called transcranial direct current stimulation (tDCS) to aid children in recovering from mild traumatic brain injuries (mTBI), such as concussions. The researchers aim to determine if tDCS can improve communication between brain areas to alleviate motor and cognitive issues. Children who have experienced a concussion in the past year and face symptoms like difficulty with planning or movement may be suitable candidates. Healthy children without a concussion history will also participate for comparison. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance recovery methods for children with mTBI.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What prior data suggests that this brain stimulation method is safe for children with mild traumatic brain injury?
Research shows that transcranial direct current stimulation (tDCS) is generally safe for people. Studies have found no serious side effects, such as brain injury, linked to tDCS use. This brain stimulation method is also considered safe and well-tolerated in children, which is crucial for this trial focusing on young people with mild traumatic brain injury.
In past studies, researchers used tDCS alongside other therapies and found it safe and practical. While research continues, early results are promising for its use in improving thinking skills. Overall, tDCS is viewed as a low-risk treatment option.12345Why are researchers excited about this trial?
Unlike the standard care for mild traumatic brain injury, which often involves rest and symptom management, transcranial direct current stimulation (tDCS) offers a unique approach by directly modulating brain activity. tDCS uses a low electrical current, delivered through electrodes placed on the scalp, to target specific brain regions affected by concussion. Researchers are excited about tDCS because it has the potential to improve recovery by enhancing neural plasticity and cognitive function, providing a non-invasive and potentially faster-acting alternative to conventional treatments.
What evidence suggests that transcranial direct current stimulation (tDCS) might be an effective treatment for mild traumatic brain injury (mTBI)?
This trial will evaluate the effects of transcranial direct current stimulation (tDCS) in youth with mild traumatic brain injury (mTBI). Research has shown that tDCS can improve movement and thinking skills, with studies finding it aids recovery after a stroke by enhancing these abilities. Evidence also suggests that tDCS can enhance thinking skills in various conditions. Although researchers have studied tDCS less in mTBI, its potential to help the brain change and adapt suggests it might repair brain areas affected by mTBI. In summary, early findings are promising for tDCS as a way to aid recovery in mTBI, but more research is needed to confirm its benefits for this condition.16789
Who Is on the Research Team?
Ghazala Saleem, EdD
Principal Investigator
State University of New York at Buffalo
Are You a Good Fit for This Trial?
This trial is for children aged 10-15 who have had a mild traumatic brain injury (mTBI) or concussion in the past year and are experiencing ongoing symptoms like trouble with motor skills. They must be at least 6 weeks post-injury, speak English fluently, and have no prior history of concussions.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Assessment
Initial behavioral and neuroimaging testing conducted
Treatment
Ten sessions of 1.5 mA real tDCS and 10 sessions of sham tDCS administered with a 2-week washout period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- tDCS
Find a Clinic Near You
Who Is Running the Clinical Trial?
State University of New York at Buffalo
Lead Sponsor
National Center for Advancing Translational Sciences (NCATS)
Collaborator